Summaries of the Section H (HML) update

Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.

The table on this page gives a preview of the upcoming changes that will be announced in next month’s Section H of the Pharmaceutical Schedule.

The changes will be published in the Online HML(external link) around the 23^rd of this month and are effective from next month.

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.

16 May 2024 - preview of changes for June 2024

Pharmaceutical	Change
Atazanavir sulphate (Atazanavir Viatris) cap 200 mg	addition of PSS
Atazanavir sulphate (Atazanavir Mylan) cap 200 mg	removal of PSS and to be delisted 1 December 2024
Ciprofloxacin tab 250 mg and 500 mg	Brand change Ipca-Ciprofloxacin – new listing and addition of PSS Tab 250 mg (p’code 2676877) Tab 500 mg (p’code 2676885) Tab 250 mg (Cipflox) and tab 500 mg (Ciprofloxacin - Torrent) to be delisted from 1 November 2024
Choline salicylate with cetalkonium chloride adhesive gel 8.7% with cetalkonium chloride 0.01%	delisted 1 June 2024
Cytarabine (Cytarabine DBL) inj 100 mg per ml, 20 ml vial	new listing (p’code 341711)
Fluocortolone caproate with fluocortolone pivalate and cinchocaine (Ultraproct) Oint 950 mcg with fluocortolone pivalate 920 mcg and cinchocaine hydrochloride 5 mg per g, 30 g Suppos 630 mcg with fluocortolone pivalate 610 mcg and cinchocaine hydrochloride 1 mg	price increase
Levosimendan (Simdax) inj 2.5 mg per ml, 5 ml vial	new listing and addition of PSS (p’code 2304236)
Midazolam (Midazolam Viatris) inj 1 mg per ml, 5 ml ampoule	new listing (p’code 2634945)
Morphine sulphate (Oramorph CDC S29) oral liq 2 mg per ml, 100 ml	new listing (p’code 2679361)
Multivitamins Inj thiamine hydrochloride 250 mg with riboflavin 4 mg and pyridoxine hydrochloride 50 mg, 5 ml ampoule (1) and inj ascorbic acid 500 mg with nicotinamide 160 mg, 2 ml ampoule (1) (e.g. Pabrinex IM) Inj thiamine hydrochloride 500 mg with riboflavin 8 mg and pyridoxine hydrochloride 100 mg, 10 ml ampoule (1) and inj ascorbic acid 1000 mg with nicotinamide 320 mg and glucose 2000 mg, 10 ml ampoule (1) (e.g. Pabrinex IV)	to be delisted 1 June 2024 (example brand only)
Nadolol (Nadolol BNM) tab 40 mg and 80 mg	extended HSS expiry date
Octreotide inj depot 30 mg prefilled syringe	Brand change Sandostatin LAR – new listing (p’code 2150859) Octreotide Depot Teva – to be delisted from 1 December 2024
Oxycodone hydrochloride (Oxycodone Lucis S29) oral liq 5 mg per 5 ml, 250 ml	new listing (p’code 2678500)
Simvastatin tab 40 mg	Brand change Simvastatin Viatris – addition of PSS Simvastatin Mylan – removal of PSS and to be delisted 1 December 2024
Simvastatin tab 80 mg	Brand change Simvastatin Viatris – addition of PSS Simvastatin Mylan – removal of PSS
Sodium chloride (InterPharma) irrigation soln 0.9%, 30 ml ampoule	price increase
Sulfadiazine sodium tab 500 mg	amended chemical name

Find previous months' summaries